Mphasis Board of Directors
Get the latest insights into the leadership at Mphasis. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Amit Dalmia | Non Independent & Non Executive Director |
| David Lawrence Johnson | Non Independent & Non Executive Director |
| Marshall Lux | Non Independent & Non Executive Director |
| Nitin Rakesh | Managing Director & Chief Executive Officer |
| Amit Dixit | Non Independent & Non Executive Director |
| Maureen Anne Erasmus | Non Executive Independent Director |
| Kabir Mathur | Non Independent & Non Executive Director |
| Pankaj Sood | Non Independent & Non Executive Director |
| Girish Paranjpe | Chairman |
| Sunil Gulati | Non Executive Independent Director |
| Mayank Verma | Company Secretary & Compliance Officer |
Mphasis FAQs
The board at Mphasis consists of experienced professionals, including Amit Dalmia, David Lawrence Johnson, and others, overseeing the company’s strategic and corporate governance.
Directors at Mphasis are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Amit Dalmia is the current chairman at Mphasis.
Executive directors at Mphasis are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Mphasis adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Mphasis, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
